homocysteine and Carcinoma, Anaplastic

homocysteine has been researched along with Carcinoma, Anaplastic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, W; Guo, Y; Wen, X; Wu, W; Zhang, D1
Lukyanova, NY1
Battistelli, S; Bing, C; Roviello, F; Stefanoni, M; Vittoria, A1
Haven, TR; Sun, CF; Tsao, KC; Wu, JT; Wu, TL1
Pereira, P; Rozen, R; Sabbaghian, N; Schievella, AR; Sekhon, J1
Mangum, JH; Murray, BK; North, JA1

Reviews

1 review(s) available for homocysteine and Carcinoma, Anaplastic

ArticleYear
Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Adult; Carcinoma; Case-Control Studies; Female; Folic Acid; Folic Acid Deficiency; Gastrointestinal Neoplasms; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Urologic Neoplasms

2015

Other Studies

5 other study(ies) available for homocysteine and Carcinoma, Anaplastic

ArticleYear
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells.
    Experimental oncology, 2010, Volume: 32, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cadherins; Carcinoma; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Homocysteine; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2

2010
Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma.
    World journal of gastroenterology, 2006, Oct-14, Volume: 12, Issue:38

    Topics: Aged; Carcinoma; Cell Proliferation; Colorectal Neoplasms; Cytosine; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Thymine

2006
Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker.
    Clinica chimica acta; international journal of clinical chemistry, 2002, Volume: 321, Issue:1-2

    Topics: Biomarkers, Tumor; Carcinoma; Cell Death; Cell Division; Culture Media, Conditioned; Homocysteine; Humans; Time Factors; Tumor Cells, Cultured

2002
Antisense inhibition of methylenetetrahydrofolate reductase reduces survival of methionine-dependent tumour lines.
    British journal of cancer, 2002, Jul-15, Volume: 87, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line; Colonic Neoplasms; Enzyme Inhibitors; Exons; Female; Fibroblasts; Genetic Therapy; Homocysteine; Humans; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Proteins; Neuroblastoma; Oligodeoxyribonucleotides, Antisense; Oxidoreductases Acting on CH-NH Group Donors; RNA, Messenger; RNA, Neoplasm; Thionucleotides; Tumor Cells, Cultured; Vitamin B 12

2002
Vitamin B 12 dependent methionine biosynthesis in cultured mammalian cells.
    Biochemistry, 1969, Volume: 8, Issue:9

    Topics: Animals; Carbon Isotopes; Carcinoma; Cell Division; Cell Line; Cricetinae; Culture Media; Culture Techniques; Drug Synergism; Folic Acid; Formaldehyde; HeLa Cells; Homocysteine; Humans; Kidney; Laryngeal Neoplasms; Methionine; Stimulation, Chemical; Swine; Transferases; Vitamin B 12

1969